91 results
Page 2 of 5
8-K
EX-99.1
54k puwh8dn
5 Mar 24
2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress
7:03am
8-K
EX-99.1
j5ot4qat9cvqu
5 Feb 24
Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple
7:02am
8-K
cf01ifj7djc6h2
30 Jan 24
2seventy bio Announces New Strategic Path Forward
7:48am
8-K
EX-99.1
89pv7 6u05yu0ourtv
30 Jan 24
2seventy bio Announces New Strategic Path Forward
7:48am
8-K
EX-99.2
5dc re520tq
12 Dec 23
Regulation FD Disclosure
7:25am
8-K
EX-99.1
d2qfajao1r7ttb
20 Nov 23
Other Events
7:20am
8-K
EX-99.1
e1n1mygl2
14 Nov 23
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
12:00am
8-K
EX-99.1
5ca k4cvegct3uo6i
13 Sep 23
Unleash Time 2seventy bio company presentation September 2023
4:03pm
8-K
EX-99.1
yf4ct632aqzy
12 Sep 23
2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
7:13am
8-K
EX-99.1
lrfi3f 3p8gntj2pt
14 Aug 23
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
7:02am
8-K
EX-99.1
knwxr
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
8-K
EX-99.2
2dx4fy
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
8-K
EX-99.2
39fhf y492h3ng7md
19 May 23
Regulation FD Disclosure
6:07am
8-K
EX-99.1
ulxph29uiye94 r1
17 May 23
2seventy bio Presents Broad Range of New Data Highlighting Novel Approaches Across its Cell Therapies Portfolio
7:31am
8-K
EX-99.1
0c3wqe ggrfzsa9r7
3 May 23
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
4:11pm